Drug Trial Radar · NCT06441643
Next Generation Rocklatan
Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
646
Actual
Start
Sep 4, 2024
Primary completion
Nov 14, 2025
Study completion Nov 14, 2025
Sponsor
- Lead sponsor
- Alcon ResearchIndustry
- Sponsor type
- Industry
- First posted
- Jun 4, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this two-stage clinical trial is to assess the safety and hypotensive efficacy of AR-17043 and PG043 ophthalmic solutions in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT).
Conditions
- Open Angle Glaucoma
- Ocular Hypertension
Interventions
AR-17043 Ophthalmic SolutionDrug
Investigational monotherapy
PG043 Ophthalmic SolutionDrug
Investigational fixed dose combination
Latanoprost 0.005% Ophthalmic SolutionDrug
Marketed monotherapy
Netarsudil 0.02% Ophthalmic SolutionDrug
Marketed monotherapy
Netarsudil 0.02%/Latanoprost 0.005% Ophthalmic SolutionDrug
Marketed fixed dose combination
AR-17043 VehicleDrug
Placebo comparator
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean diurnal IOP at Day 8 (Stage 1)Time frame: Day 8 (8:00, 10:00, 12:00, 16:00)
- Mean diurnal IOP at Day 29 (Stage 2)Time frame: Day 29 (8:00, 10:00, 16:00)
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Trinity Research Group
Dothan, Alabama
Eye Doctors of Arizona
Phoenix, Arizona
Orange County Ophthalmology Medical Group
Garden Grove, California
United Medical Research Institute
Inglewood, California
Eye Research Foundation
Newport Beach, California
North Bay Eye Associates
Petaluma, California
Eye Center of Northern Colorado, PC
Fort Collins, Colorado
Bruce A. Segal MD
Delray Beach, Florida
Glaucoma Specialists of South Florida
Delray Beach, Florida
Central Florida Eye Associates
Lakeland, Florida
Mid Florida Eye Center
Mt. Dora, Florida
Center For Sight
Venice, Florida
Coastal Research Associates
Roswell, Georgia
Moyes Eye Center
Kansas City, Missouri
Rochester Ophthalmological Group
Rochester, New York
James D. Branch Ophthalmology
Winston-Salem, North Carolina
Bergstrom Eye Research
Fargo, North Dakota
Midwest Eye Center
Cincinnati, Ohio
Cincinnati Eye Institute
Cincinnati, Ohio
Scott & Christie and Associates, PC
Cranberry Township, Pennsylvania
Carolina Eyecare Physicians LLC
Mt. Pleasant, South Carolina
University Eye Specialists
Maryville, Tennessee
Total Eye Care PA
Memphis, Tennessee
Key-Whitman Eye Center
Dallas, Texas
Piedmont Eye Center
Lynchburg, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.